Product References

Development of a dual antigen lateral flow immunoassay for detecting Yersinia pestis

Posted by Adam Awdish on

Development of a dual antigen lateral flow immunoassay for detecting Yersinia pestis

Pooled Human Serum Off The Clot from Innovative Research was used in the following study:   Development of a dual antigen lateral flow immunoassay for detecting Yersinia pestis Derrick Hau,Brian Wade, Chris Lovejoy, Sujata G. Pandit, Dana E. Reed, Haley L. DeMers, Heather R. Green, Emily E. Hannah, Megan E. McLarty, Cameron J. Creek, Chonnikarn Chokapirat, Jose Arias-Umana, Garett F. Cecchini, Teerapat Nualnoi, Marcellene A. Gates-Hollingsworth, Peter N. Thorkildson, Kathryn J. Pflughoeft, David P. AuCoin PLOS March 23, 2022 Yersinia pestis is a gram-negative bacterium that is the cause for plague in mammals, presenting itself in three distinct forms. Specifically,...

Read more →

PD-LAMP Smartphone Detection of SARS-CoV-2 on Chip

Posted by Adam Awdish on

PD-LAMP Smartphone Detection of SARS-CoV-2 on Chip

Pooled Human Saliva from Innovative Research was used in the following study:   PD-LAMP Smartphone Detection of SARS-CoV-2 on Chip Ashlee J. Colbert, Dong Hoon Lee, Katherine N. Clayton, Steven T. Wereley, Jacqueline C. Linnes, Tamara L. Kinzer-Ursem Analytica Chimica Acta March 7, 2022 Part of why SARS-CoV-2 (COVID-19) has been able to reach pandemic levels is because it can have a long incubation period prior to the normal onset of symptoms, and further, it doesn’t always cause symptoms in infected individuals. On top of this, symptoms can range in severity between patients, and milder symptoms caused by COVID-19 can easily...

Read more →

Effect of Photo-Mediated Ultrasound Therapy on Nitric Oxide and Prostacyclin from Endothelial Cells

Posted by Adam Awdish on

Effect of Photo-Mediated Ultrasound Therapy on Nitric Oxide and Prostacyclin from Endothelial Cells

Innovative Grade US Origin Monkey Rhesus Whole Blood from Innovative Research was used in the following study:   Effect of Photo-Mediated Ultrasound Therapy on Nitric Oxide and Prostacyclin from Endothelial Cells Madhumithra Subramanian Karthikesh, Sa Wu, Rohit Singh, Yannis Paulus, Xueding Wang and Xinmai Yang Applied Sciences March 3, 2022 Photo-mediated ultrasound therapy (PUT) is a form of non-invasive imaging technique that uses synchronized ultrasound bursts and laser pulses to produce a photoacoustic image and seems to be very precise in blood vessel targeting. Further, PUT has been shown to cause limited damage to healthy tissues surrounding the area of...

Read more →

Near-Infrared-Driven Photoablation of Lung Cancer Tumors Utilizing Biomimetic Platelet-Polyethyleneimine-Polypyrrole Drug-Free Nanoparticles

Posted by Adam Awdish on

Near-Infrared-Driven Photoablation of Lung Cancer Tumors Utilizing Biomimetic Platelet-Polyethyleneimine-Polypyrrole Drug-Free Nanoparticles

Single Donor Human Platelets ACD from Innovative Research was used in the following study:   Near-Infrared-Driven Photoablation of Lung Cancer Tumors Utilizing Biomimetic Platelet-Polyethyleneimine-Polypyrrole Drug-Free Nanoparticles Burnouf, T.; Jheng, P-R.; Chen, Y-H.; Rethi, L.; Rethi, L.; Lu, L-S.; Ho, Y-C.; Chuang, E-Y. Materials & Design February 20, 2022 In the field of cancer treatment, intraperitoneal (IP) administration can be used to deliver drugs to a patient, however, it doesn’t distinguish between tumors and healthy tissues, opening the potential for harm to healthy organs during treatment. One of several newer approaches to cancer treatment, photothermal therapy (PTT), is currently a topic...

Read more →

A Very Long-Acting IL-15: Implications for the Immunotherapy of Cancer

Posted by Adam Awdish on

A Very Long-Acting IL-15: Implications for the Immunotherapy of Cancer

Innovative Grade US Origin Mouse C57BL6 Plasma from Innovative Research was used in the following study:   A Very Long-Acting IL-15: Implications for the Immunotherapy of Cancer John A. Hangasky, Wei Chen, Sigrid Dubois, Anusara Daenthanasanmak, Jürgen Müller, Ralph Reid, Thomas A. Waldmann, and Daniel V. Santi Journal for Immunotherapy of Cancer January 31, 2022 Interleukin-15 (IL-15) is a protein essential for maintenance and survival of natural killer (NK) and CD8+ T cells, making it an interleukin of interest as an immune-oncology agent. IL-2 and IL-15 both bind to NK and CD8+ T cells, however, regulatory T cells are primarily...

Read more →


×